MedTrace Logo

Ketamine Infusion Therapy for the Treatment of PTSD in Paramedics

NCT03947099 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2021-02-26

No results posted yet for this study

Summary

This is an observational study to assess the change in several psychological screening tools before and after a series of six ketamine infusions in paramedics who suffer from post traumatic stress disorder as a result of working in emergency medical services.

Conditions

  • Stress Disorders, Post-Traumatic
  • Anxiety Disorders

Interventions

DRUG

Ketamine Hydrochloride

Participants are treated with six one-hour infusions of ketamine hydrochloride over a three week period in hopes of treating symptoms of PTSD.

Sponsors & Collaborators

  • Klarisana Physician Services PLLC

    lead INDUSTRY

Principal Investigators

  • Carl J Bonnett, MD · Klarisana Physician Services PLLC

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-02
Primary Completion
2021-02-22
Completion
2021-02-22
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03947099 on ClinicalTrials.gov